Abstract
After over two decades of intensive research, a variety of smoking cessation strategies, both behavioral and pharmacotherapeutic, have been developed and clinically validated. In this review, pharmacological products available for smoking cessation are profiled and examined for efficacy. Results of a recent comprehensive review and meta-analysis by the Agency for Health Care Policy and Research on the effects of behavior therapy on smoking cessation are also discussed. Further, meta-analyses and studies exploring the important interaction between pharmacological and behavioral therapies are considered. Applications of the growing wealth of smoking cessation strategies are discussed with respect to the needs of some special subpopulations of smokers including highly nicotine-dependent smokers and smokers with comorbid psychiatric diagnoses.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 11-38 |
| Number of pages | 28 |
| Journal | Journal of Clinical Psychology in Medical Settings |
| Volume | 6 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1999 |
Bibliographical note
Funding Information:This work was supported by NIDA grants P50-DA09259 and 2T32-DA07097.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Behavior therapy
- Health psychology
- Nicotine dependence
- Smoking cessation
Fingerprint
Dive into the research topics of 'Pharmacological and Behavioral Strategies for Smoking Cessation'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS